Docusign (NASDAQ:DOCU) CRO Sells $427,980.00 in Stock

Key Points

• Docusign's CRO, Paula Hansen, sold 6,000 shares for a total of $427,980, reducing her ownership by 9.24% to approximately 58,968 shares valued at about $4.2 million.
• The company's recent quarterly earnings exceeded expectations, reporting $0.92 EPS and revenue of $800.64 million, showcasing an 8.8% year-over-year growth.
• Multiple analysts have raised their price targets for Docusign, with an average target price now at $94.14 and a consensus rating of "Hold".

Docusign Inc. (NASDAQ:DOCU - Get Free Report) CRO Paula Hansen sold 6,000 shares of the company's stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $71.33, for a total transaction of $427,980.00. Following the sale, the executive owned 58,968 shares of the company's stock, valued at approximately $4,206,187.44. The trade was a 9.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Docusign Price Performance

NASDAQ DOCU traded up $1.60 during trading on Wednesday, hitting $71.54. 2,672,304 shares of the company's stock traded hands, compared to its average volume of 2,790,160. The stock has a fifty day moving average of $75.81 and a two-hundred day moving average of $78.83. Docusign Inc. has a 12-month low of $66.35 and a 12-month high of $107.86. The firm has a market cap of $14.39 billion, a P/E ratio of 53.79, a PEG ratio of 3.59 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business had revenue of $800.64 million during the quarter, compared to analyst estimates of $780.35 million. During the same period in the prior year, the business posted $0.97 earnings per share. The company's revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, analysts expect that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Institutional Trading of Docusign

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Norges Bank bought a new position in shares of Docusign during the second quarter valued at approximately $140,987,000. Wellington Management Group LLP lifted its holdings in shares of Docusign by 372.5% during the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after purchasing an additional 1,440,269 shares during the last quarter. Duquesne Family Office LLC purchased a new position in shares of Docusign during the first quarter valued at approximately $87,477,000. Pacer Advisors Inc. lifted its holdings in shares of Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock valued at $95,017,000 after purchasing an additional 1,038,962 shares during the last quarter. Finally, Third Point LLC purchased a new position in shares of Docusign during the second quarter valued at approximately $48,681,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on DOCU. Morgan Stanley upped their price target on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research report on Monday, September 8th. UBS Group set a $95.00 target price on shares of Docusign in a report on Friday, September 5th. JPMorgan Chase & Co. increased their target price on shares of Docusign from $77.00 to $80.00 and gave the stock a "neutral" rating in a report on Friday, September 5th. Argus reiterated a "hold" rating on shares of Docusign in a report on Monday, September 8th. Finally, Robert W. Baird increased their target price on shares of Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fifteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $94.14.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.